Dan Laheru

18.8k total citations
69 papers, 2.1k citations indexed

About

Dan Laheru is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dan Laheru has authored 69 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 18 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dan Laheru's work include Pancreatic and Hepatic Oncology Research (32 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Cancer Genomics and Diagnostics (17 papers). Dan Laheru is often cited by papers focused on Pancreatic and Hepatic Oncology Research (32 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Cancer Genomics and Diagnostics (17 papers). Dan Laheru collaborates with scholars based in United States, Canada and Argentina. Dan Laheru's co-authors include Elizabeth M. Jaffee, Joseph M. Herman, Dung T. Le, Barbara Biedrzycki, Beth Onners, Elizabeth A. Sugar, Irena Tartakovsky, Sara Solt, Vijak Mahdavi and Leslie Smoot and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nature reviews. Cancer.

In The Last Decade

Dan Laheru

66 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dan Laheru United States	19	1.4k	668	505	351	298	69	2.1k
Christopher L. Wolfgang United States	21	1.6k 1.1×	753 1.1×	399 0.8×	273 0.8×	322 1.1×	62	2.0k
Ursina Teitelbaum United States	19	1.9k 1.4×	1.2k 1.8×	596 1.2×	279 0.8×	452 1.5×	54	2.7k
Todd T. Moore United States	12	1.8k 1.3×	1.4k 2.1×	686 1.4×	257 0.7×	373 1.3×	17	2.8k
Serena S. Kwek United States	20	1.5k 1.1×	1.2k 1.8×	701 1.4×	323 0.9×	236 0.8×	27	2.3k
Jason Madore Australia	25	1.6k 1.1×	1.0k 1.5×	756 1.5×	459 1.3×	320 1.1×	32	2.5k
Dario Sangiolo Italy	25	1.4k 1.0×	1.1k 1.6×	549 1.1×	442 1.3×	200 0.7×	76	2.2k
Angelo De Marzo United States	15	867 0.6×	399 0.6×	839 1.7×	332 0.9×	371 1.2×	23	1.7k
Kuniaki Aridome Japan	21	748 0.5×	572 0.9×	504 1.0×	368 1.0×	162 0.5×	38	1.7k
Yu Kato Japan	15	1.8k 1.2×	1.5k 2.2×	472 0.9×	348 1.0×	215 0.7×	30	2.7k
Sofia R. Gameiro United States	28	1.9k 1.3×	1.5k 2.3×	609 1.2×	556 1.6×	208 0.7×	59	2.7k

Countries citing papers authored by Dan Laheru

Since Specialization

Citations

This map shows the geographic impact of Dan Laheru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Laheru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Laheru more than expected).

Fields of papers citing papers by Dan Laheru

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Laheru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Laheru. The network helps show where Dan Laheru may publish in the future.

Co-authorship network of co-authors of Dan Laheru

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Laheru. A scholar is included among the top collaborators of Dan Laheru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Laheru. Dan Laheru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Knox, Jennifer J., Elizabeth M. Jaffee, Grainne M. O’Kane, et al.. (2024). Early results of the PASS-01 trial: Pancreatic adenocarcinoma signature stratification for treatment-01.. Journal of Clinical Oncology. 42(17_suppl). LBA4004–LBA4004. 6 indexed citations

Zheng, Lei, Dan Laheru, Ana De Jesus‐Acosta, et al.. (2024). Outcomes in patients with pancreatic and ampullary cancer whose tumors harbor pathogenic APC mutations.. Journal of Clinical Oncology. 42(3_suppl). 693–693.

Christenson, Eric S., Jennifer N. Durham, Hao Wang, et al.. (2024). A phase 2 study evaluating response and biomarkers in patients with microsatellite stable (MSS) advanced colorectal cancer (CRC) treated with nivolumab/relatlimab.. Journal of Clinical Oncology. 42(16_suppl). 3554–3554. 1 indexed citations

Baydogan, Seyda, Parul Agarwal, Dan Laheru, et al.. (2023). Prevalence of germline variants in patients with pancreatic neuroendocrine tumors.. Journal of Clinical Oncology. 41(16_suppl). 4135–4135. 1 indexed citations

Le, Dung T., Jennifer N. Uram, Hao Wang, et al.. (2016). Programmed death-1 blockade in mismatch repair deficient colorectal cancer.. Journal of Clinical Oncology. 34(15_suppl). 103–103. 85 indexed citations

Grossman, Stuart A., Susannah G. Ellsworth, Jian Campian, et al.. (2015). Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors. Journal of the National Comprehensive Cancer Network. 13(10). 1225–1231. 234 indexed citations

Kumar, Abhijeet, Meenakshi Dagar, Joseph M. Herman, Christine A. Iacobuzio–Donahue, & Dan Laheru. (2014). CNS Involvement in Pancreatic Adenocarcinoma: a Report of Eight Cases from the Johns Hopkins Hospital and Review of Literature. Journal of Gastrointestinal Cancer. 46(1). 5–8. 19 indexed citations

Le, Dung T., Andrea Wang‐Gillam, Vincent J. Picozzi, et al.. (2014). A phase 2, randomized trial of GVAX pancreas and CRS-207 immunotherapy versus GVAX alone in patients with metastatic pancreatic adenocarcinoma: Updated results.. Journal of Clinical Oncology. 32(3_suppl). 177–177. 25 indexed citations

Wilky, Breelyn A., Michelle A. Rudek, Dan Laheru, et al.. (2014). A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours. British Journal of Cancer. 112(1). 24–31. 35 indexed citations

10.

Laheru, Dan, Barbara Biedrzycki, & Elizabeth M. Jaffee. (2012). Development of a Cytokine-Modified Allogeneic Whole Cell Pancreatic Cancer Vaccine. Methods in molecular biology. 980. 175–203. 11 indexed citations

11.

Finn, Richard S., Milind Javle, Benjamin Tan, et al.. (2012). A phase I study of MEK inhibitor MEK162 (ARRY-438162) in patients with biliary tract cancer.. Journal of Clinical Oncology. 30(4_suppl). 220–220. 44 indexed citations

12.

Díaz, Luis A., et al.. (2012). A phase I/IIA safety study of NPC-1C: A novel, therapeutic antibody to treat pancreas and colorectal cancers.. Journal of Clinical Oncology. 30(4_suppl). 233–233. 1 indexed citations

13.

Yeo, Charles J., Keith D. Lillemoe, Barbara Biedrzycki, et al.. (2011). A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma. Annals of Surgery. 253(2). 328–335. 295 indexed citations

14.

Narang, Amol, Robert C. Miller, Charles C. Hsu, et al.. (2011). Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital - Mayo Clinic collaborative study. Radiation Oncology. 6(1). 126–126. 78 indexed citations

15.

Laheru, Dan, Eric R. Lutz, James M. Burke, et al.. (2008). Allogeneic Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation. Clinical Cancer Research. 14(5). 1455–1463. 259 indexed citations

16.

Messersmith, Wells A., Antonio Jimeno, David S. Ettinger, et al.. (2008). Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 63(1). 181–188. 28 indexed citations

17.

Laheru, Dan, Charles J. Yeo, Barbara Biedrzycki, et al.. (2007). A safety and efficacy trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene in combination with adjuvant chemoradiotherapy for the treatment of adenocarcinoma of the pancreas. Journal of Clinical Oncology. 25(18_suppl). 3010–3010. 15 indexed citations

18.

Laheru, Dan & Elizabeth M. Jaffee. (2005). Immunotherapy for pancreatic cancer — science driving clinical progress. Nature reviews. Cancer. 5(6). 459–467. 158 indexed citations

19.

Hruban, Ralph H., Marcia Irene Canto, Constance A. Griffin, et al.. (2005). Treatment of familial pancreatic cancer and its precursors. Current Treatment Options in Gastroenterology. 8(5). 365–375. 12 indexed citations

20.

Laheru, Dan, Barbara Biedrzycki, Amy Thomas, & Elizabeth M. Jaffee. (2004). Development of a Cytokine-Modified Allogeneic Whole Cell Pancreatic Cancer Vaccine. Humana Press eBooks. 103. 299–328. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact